Shopping Cart
Remove All
Your shopping cart is currently empty
Thalidomide-PEG3-NH2 is a synthesized conjugate consisting of an E3 ligase ligand-linker conjugate that combines a Thalidomide-based cereblon ligand and a linker used in PROTAC technology.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry | |
| 100 mg | Inquiry | Inquiry | Inquiry |
| Description | Thalidomide-PEG3-NH2 is a synthesized conjugate consisting of an E3 ligase ligand-linker conjugate that combines a Thalidomide-based cereblon ligand and a linker used in PROTAC technology. |
| In vitro | PROTACs consist of two ligands linked together; one targets an E3 ubiquitin ligase and the other targets the specific protein. They utilize the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. |
| Synonyms | Thalidomide-PEG3-NH2 |
| Molecular Weight | 405.407 |
| Formula | C19H23N3O7 |
| Cas No. | 1957236-10-0 |
| Smiles | NCCOCCOCCOc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.